Abstract:Background: Gastric cancer is a common malignant tumor of the digestive system worldwide, and its early diagnosis is crucial to improve the survival rate of patients. Indocyanine green fluorescence imaging (ICG-FI), as a new imaging technology, has shown potential application prospects in oncology surgery. The meta-analysis to study the application value of ICG-FI in the diagnosis of gastric cancer sentinel lymph node biopsy is helpful to comprehensively evaluate the clinical effect of this technology and provide more reliable guidance for clinical practice. Aim: To assess the diagnostic efficacy of optical imaging in conjunction with indocyanine green (ICG)-guided sentinel lymph node (SLN) biopsy for gastric cancer. Methods: Electronic databases such as PubMed, Embase, Medline, Web of Science, and the Cochrane Library were searched for prospective diagnostic tests of optical imaging combined with ICG-guided SLN biopsy. Stata 12.0 software was used for analysis by combining the "bivariable mixed effect model" with the "midas" command. The true positive value, false positive value, false negative value, true negative value, and other information from the included literature were extracted. A literature quality assessment map was drawn to describe the overall quality of the included literature. A forest plot was used for heterogeneity analysis, and P < 0.01 was considered to indicate statistical significance. A funnel plot was used to assess publication bias, and P < 0.1 was considered to indicate statistical significance. The summary receiver operating characteristic (SROC) curve was used to calculate the area under the curve (AUC) to determine the diagnostic accuracy. If there was interstudy heterogeneity (I 2 > 50%), meta-regression analysis and subgroup analysis were performed. Results: Optical imaging involves two methods: Near-infrared (NIR) imaging and fluorescence imaging. A combination of optical imaging and ICG-guided SLN biopsy was useful for diagnosis. The positive likelihood ratio was 30.39 (95%CI: 0.92-1.00), the sensitivity was 0.95 (95%CI: 0.82-0.99), and the specificity was 1.00 (95%CI: 0.92-1.00). The negative likelihood ratio was 0.05 (95%CI: 0.01-0.20), the diagnostic odds ratio was 225.54 (95%CI: 88.81-572.77), and the SROC AUC was 1.00 (95%CI: The crucial values were sensitivity = 0.95 (95%CI: 0.82-0.99) and specificity = 1.00 (95%CI: 0.92-1.00). The Deeks method revealed that the "diagnostic odds ratio" funnel plot of SLN biopsy for gastric cancer was significantly asymmetrical (P = 0.01), suggesting significant publication bias. Further meta-subgroup analysis revealed that, compared with fluorescence imaging, NIR imaging had greater sensitivity (0.98 vs 0.73). Compared with optical imaging immediately after ICG injection, optical imaging after 20 minutes obtained greater sensitivity (0.98 vs 0.70). Compared with that of patients with an average SLN detection number < 4, the sensitivity of patients with a SLN detection number ≥ 4 was greater (0.96 vs 0.68). Compared with hematoxylin-eosin (HE) staining, immunohistochemical (+ HE) staining showed greater sensitivity (0.99 vs 0.84). Compared with subserous injection of ICG, submucosal injection achieved greater sensitivity (0.98 vs 0.40). Compared with 5 g/L ICG, 0.5 and 0.05 g/L ICG had greater sensitivity (0.98 vs 0.83), and cT1 stage had greater sensitivity (0.96 vs 0.72) than cT2 to cT3 clinical stage. Compared with that of patients ≤ 26, the sensitivity of patients > 26 was greater (0.96 vs 0.65). Compared with the literature published before 2010, the sensitivity of the literature published after 2010 was greater (0.97 vs 0.81), and the differences were statistically significant (all P < 0.05). Conclusion: For the diagnosis of stomach cancer, optical imaging in conjunction with ICG-guided SLN biopsy is a therapeutically viable approach, especially for early gastric cancer. The concentration of ICG used in the SLN biopsy of gastric cancer may be too high. Moreover, NIR imaging is better than fluorescence imaging and may obtain higher sensitivity.

Clinical significance of breast-specific gamma imaging in diagnosis of breast cancer

Breast-Specific Gamma Imaging with Tc-99m-Sestamibi in the Diagnosis of Breast Cancer and Its Semiquantitative Index Correlation with Tumor Biologic Markers, Subtypes, and Clinicopathologic Characteristics

Visual and Semi-Quantitative Analyses of Dual-Phase Breast-Specific Gamma Imaging with Tc-99m-sestamibi in Detecting Primary Breast Cancer.

Efficacy of the Image Features of Breast-Specific Gamma Imaging in the Differential Diagnosis of Breast Lesions

Diagnostic Value of Breast Specific Gamma Imaging with Combined Visual and Semi-Quantitative Method in Patients with Breast Carcinoma

Value of Breast Specific Gamma Imaging in the Diagnosis of Breast Carcinoma

Comparison of BSGI, MRI, mammography, and ultrasound for the diagnosis of breast lesions and their correlations with specific molecular subtypes in Chinese women

Breast-specific gamma imaging or ultrasonography as adjunct imaging diagnostics in women with mammographically dense breasts

Application of Breast Ultrasound Imaging Report and Data System classification in diagnosis of special types of breast cancer

Retrospective and Comparative Analysis of 99Mtc-Sestamibi Breast Specific Gamma Imaging Versus Mammography, Ultrasound, and Magnetic Resonance Imaging for the Detection of Breast Cancer in Chinese Women

Retrospective and comparative analysis of 99m Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women

Comparison of the Diagnostic Value among Different Examination Methods for Breast Cancer

Application value of indocyanine green fluorescence imaging in guiding sentinel lymph node biopsy diagnosis of gastric cancer: Meta-analysis

Comparative Study of Handheld Ultrasound ,automated Breast Volume Scanner and Breast Specific Gamma Imaging in the Diagnosis of Breast Cancer

Role of BI-RADS in Guiding Surgical Inter Vention of Non-Palpable, Ultrasound-Negative and Mammography-Suspicious Breast Lesions

Clinical value of mammography in diagnosis and identification of breast mass

The Application of Breast Specific Gamma Imaging and Positron Emission Mammography in the Diagnosis and Therapy of Breast Cancer

[The Effect of Breast Cancer Specific Gene 1 in the Prognosis of Breast Cancer].

Study of gemstone spectral imaging in diagnosis of gastric cancer

The Use of Breast-specific Gamma Imaging as a Low-Cost Problem-Solving Strategy for Avoiding Biopsies in Patients With Inconclusive Imaging Findings on Mammography and Ultrasonography

Value of Multimodal Imaging in the Diagnosis of Breast Sclerosing Adenosis Associated with Malignant Lesions.